Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Cash from Investing Activities (2012 - 2026)

Rezolute (RZLT) posted Cash from Investing Activities of $12.3 million for Q1 2026, down 46.17% sequentially from $22.8 million in Q4 2025, and down 46.73% YoY from $23.1 million in Q1 2025.

Analysis

Rezolute (RZLT) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Rezolute has reported Cash from Investing Activities for 13 years, with the latest figure at $12.3 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 46.73% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.0 million (down 792.0% YoY) and the FY2025 annual result came in at -$14.5 million, down 129.86% from the prior year.
  • Cash from Investing Activities declined to $12.3 million in Q1 2026 per RZLT's latest filing, from $22.8 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $23.1 million in Q1 2025 and troughed at -$95.0 million in Q1 2023.
  • A 5-year average of -$6.7 million and a median of $2.6 million in 2023 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities soared 21497.59% in 2023, then sank 1996.01% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$83000.0 in 2022, then jumped by 21497.59% to $17.8 million in 2023, then sank by 35.42% to $11.5 million in 2024, then soared by 98.92% to $22.8 million in 2025, then sank by 46.17% to $12.3 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $12.3 million, $22.8 million, and -$68.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Rezolute 477.02 Mn 477.02 Mn - 12.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 12.28 Mn
Dec 31, 2025 22.81 Mn
Sep 30, 2025 -68.49 Mn
Jun 30, 2025 346,000.00
Mar 31, 2025 23.05 Mn
Dec 31, 2024 11.47 Mn
Sep 30, 2024 -49.41 Mn
Jun 30, 2024 19.66 Mn
Mar 31, 2024 8.67 Mn
Dec 31, 2023 17.76 Mn
Sep 30, 2023 2.61 Mn
Jun 30, 2023 -6.36 Mn
Mar 31, 2023 -94.95 Mn
Dec 31, 2022 -83,000.00
Sep 30, 2022 -70,000.00
Jun 30, 2019 -6,000.00
Mar 31, 2019 41,861.00
Dec 31, 2018 8,000.00
Sep 30, 2018 187,139.00
Jun 30, 2018 1.55 Mn